{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:54:23Z","timestamp":1793987663917,"version":"4.8.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shaanxi Provincial Natural Science Basic Research Program","award":["2024JC-YBQN-0817"],"award-info":[{"award-number":["2024JC-YBQN-0817"]}]},{"name":"Science and Technology Program of Jiaxing","award":["2022AD30058"],"award-info":[{"award-number":["2022AD30058"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06221-w","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:26:16Z","timestamp":1783135576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of lipoprotein(a) with left ventricular dysfunction in patients with chronic total occlusion of the coronary artery"],"prefix":"10.1186","volume":"26","author":[{"given":"Suining","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lele","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"key":"6221_CR1","doi-asserted-by":"publisher","first-page":"753250","DOI":"10.3389\/fcvm.2022.753250","volume":"9","author":"L Guo","year":"2022","unstructured":"Guo L, Lv H, Yin X. Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Prior Coronary Artery Bypass Graft: Current Evidence and Future Perspectives. Front Cardiovasc Med. 2022;9:753250.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"6221_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s43044-020-00065-1","volume":"72","author":"WS El Awady","year":"2020","unstructured":"El Awady WS, Samy M, Al-Daydamony MM, Abd El Samei MM, Shokry K. Periprocedural and clinical outcomes of percutaneous coronary intervention of chronic total occlusions in patients with low- and mid-range ejection fractions. Egypt Heart J. 2020;72(1):28.","journal-title":"Egypt Heart J"},{"key":"6221_CR3","doi-asserted-by":"publisher","first-page":"1019688","DOI":"10.3389\/fcvm.2022.1019688","volume":"9","author":"S Zhao","year":"2022","unstructured":"Zhao S, Chen Y, Zhu B, Wang J, Wei Z, Zou Y, Hu W, Chen G, Wang H, Xia C, et al. Percutaneous coronary intervention improves quality of life of patients with chronic total occlusion and low estimated glomerular filtration rate. Front Cardiovasc Med. 2022;9:1019688.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"6221_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcin.2021.09.027","volume":"15","author":"L Azzalini","year":"2022","unstructured":"Azzalini L, Karmpaliotis D, Santiago R, Mashayekhi K, Di Mario C, Rinfret S, Nicholson WJ, Carlino M, Yamane M, Tsuchikane E, et al. Contemporary Issues in Chronic Total Occlusion Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2022;15(1):1\u201321.","journal-title":"JACC Cardiovasc Interv"},{"key":"6221_CR5","doi-asserted-by":"publisher","first-page":"1202718","DOI":"10.3389\/fphar.2023.1202718","volume":"14","author":"N Li","year":"2023","unstructured":"Li N, Gu X, Liu F, Zhang Y, Sun Y, Gao S, Wang B, Zhang C. Network pharmacology-based analysis of potential mechanisms of myocardial ischemia-reperfusion injury by total salvianolic acid injection. Front Pharmacol. 2023;14:1202718.","journal-title":"Front Pharmacol"},{"key":"6221_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.hjc.2022.12.001","volume":"69","author":"Z Li","year":"2023","unstructured":"Li Z, Wang Y, Wu S, Xiao J, Guo L, Meng S, Zhong L, Ding H, Lv H, Zhou X, et al. Good coronary collateral circulation is not associated with better prognosis in patients with chronic total occlusion, regardless of treatment strategy. Hellenic J Cardiol. 2023;69:9\u201315.","journal-title":"Hellenic J Cardiol"},{"key":"6221_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3389\/fcvm.2020.00116","volume":"7","author":"L Guo","year":"2020","unstructured":"Guo L, Zhang X, Lv H, Zhong L, Wu J, Ding H, Xu J, Zhou X, Huang R. Long-Term Outcomes of Successful Revascularization for Patients With Coronary Chronic Total Occlusions: A Report of 1,655 Patients. Front Cardiovasc Med. 2020;7:116.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"6221_CR8","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1161\/ATV.0000000000000147","volume":"42","author":"G Reyes-Soffer","year":"2022","unstructured":"Reyes-Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR, Lloyd-Jones DM, Marcovina SM, Yeang C, Koschinsky ML, et al. Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol. 2022;42(1):e48\u201360.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"6221_CR9","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3390\/molecules28030969","volume":"28","author":"S Lampsas","year":"2023","unstructured":"Lampsas S, Xenou M, Oikonomou E, Pantelidis P, Lysandrou A, Sarantos S, Goliopoulou A, Kalogeras K, Tsigkou V, Kalpis A, et al. Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment. Molecules. 2023;28(3):969.","journal-title":"Molecules"},{"issue":"1","key":"6221_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12933-019-0888-z","volume":"18","author":"Y Shen","year":"2019","unstructured":"Shen Y, Chen S, Dai Y, Wang XQ, Zhang RY, Yang ZK, Hu J, Lu L, Ding FH, Shen WF. Lipoprotein (a) interactions with cholesterol-containing lipids on angiographic coronary collateralization in type 2 diabetic patients with chronic total occlusion. Cardiovasc Diabetol. 2019;18(1):82.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"6221_CR11","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1001\/jamacardio.2024.1874","volume":"9","author":"NS Nurmohamed","year":"2024","unstructured":"Nurmohamed NS, Gaillard EL, Malkasian S, de Groot RJ, Ibrahim S, Bom MJ, Kaiser Y, Earls JP, Min JK, Kroon J, et al. Lipoprotein(a) and Long-Term Plaque Progression, Low-Density Plaque, and Pericoronary Inflammation. JAMA Cardiol. 2024;9(9):826\u201334.","journal-title":"JAMA Cardiol"},{"key":"6221_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.amjcard.2025.02.034","volume":"245","author":"M Jha","year":"2025","unstructured":"Jha M, McCarthy IR, Gelfand EV. Lipoprotein(a) - From Biomarker to Therapy: A Review for the Clinician. Am J Cardiol. 2025;245:42\u201353.","journal-title":"Am J Cardiol"},{"issue":"Suppl","key":"6221_CR13","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.2337\/dc15-S005","volume":"38","author":"American Diabetes Association","year":"2015","unstructured":"American Diabetes Association. (2) Classification and diagnosis of diabetes. Diabetes Care. 2015;38(Suppl):S8\u201316.","journal-title":"Diabetes Care"},{"issue":"12","key":"6221_CR14","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, Muiesan ML, Tsioufis K, Agabiti-Rosei E, Algharably EAE, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874\u20132071.","journal-title":"J Hypertens"},{"issue":"6","key":"6221_CR15","doi-asserted-by":"publisher","first-page":"e051121189015","DOI":"10.2174\/1573403X16999201210200342","volume":"17","author":"A Alloubani","year":"2021","unstructured":"Alloubani A, Nimer R, Samara R. Relationship between Hyperlipidemia, Cardiovascular Disease and Stroke: A Systematic Review. Curr Cardiol Rev. 2021;17(6):e051121189015.","journal-title":"Curr Cardiol Rev"},{"issue":"4","key":"6221_CR16","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1161\/01.CIR.82.4.1193","volume":"82","author":"SG Ellis","year":"1990","unstructured":"Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Bulle TM. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation. 1990;82(4):1193\u2013202.","journal-title":"Circulation"},{"issue":"14","key":"6221_CR17","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1161\/CIRCULATIONAHA.118.031313","volume":"139","author":"SW Lee","year":"2019","unstructured":"Lee SW, Lee PH, Ahn JM, Park DW, Yun SC, Han S, Kang H, Kang SJ, Kim YH, Lee CW, Park SW, et al. Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion. Circulation. 2019;139(14):1674\u201383.","journal-title":"Circulation"},{"issue":"11","key":"6221_CR18","doi-asserted-by":"publisher","first-page":"782","DOI":"10.4067\/s0034-98872025001100782","volume":"153","author":"GC Del Castillo","year":"2025","unstructured":"Del Castillo GC, Silvio SA, Colmenares ML, Begazo GA, Varleta OP. Extensi\u00f3n y severidad de la cardiopat\u00eda coronaria relacionada con niveles de lipoprote\u00edna A en pacientes hospitalizados en Unidad de Cuidados Cr\u00edticos Cardiol\u00f3gicos (Registro DIPCOL) [Extension and Severity of Coronary Heart Disease Related to Lipoprotein A Levels in Patients Hospitalized in a Cardiac Intensive Care Unit (DIPCOL Registry)]. Rev Med Chil. 2025;153(11):782\u201392.","journal-title":"Rev Med Chil"},{"issue":"24","key":"6221_CR19","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","volume":"41","author":"J Bor\u00e9n","year":"2020","unstructured":"Bor\u00e9n J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, Daemen MJ, Demer LL, Hegele RA, Nicholls SJ, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2020;41(24):2313\u201330.","journal-title":"Eur Heart J"},{"issue":"39","key":"6221_CR20","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","volume":"43","author":"F Kronenberg","year":"2022","unstructured":"Kronenberg F, Mora S, Stroes E, Ference BA, Arsenault BJ, Berglund L, Dweck MR, Koschinsky M, Lambert G, Mach F, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43(39):3925\u201346.","journal-title":"Eur Heart J"},{"issue":"2","key":"6221_CR21","doi-asserted-by":"publisher","first-page":"e002060","DOI":"10.1136\/openhrt-2022-002060","volume":"9","author":"SE Nissen","year":"2022","unstructured":"Nissen SE, Wolski K, Cho L, Nicholls SJ, Kastelein J, Leitersdorf E, Landmesser U, Blaha M, Lincoff AM, Morishita R, et al. Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease. Open Heart. 2022;9(2):e002060.","journal-title":"Open Heart"},{"issue":"8","key":"6221_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11883-021-00937-0","volume":"23","author":"A Langsted","year":"2021","unstructured":"Langsted A, Nordestgaard BG. Genetics of Lipoprotein(a): Cardiovascular Disease and Future Therapy. Curr Atheroscler Rep. 2021;23(8):46.","journal-title":"Curr Atheroscler Rep"},{"issue":"23","key":"6221_CR23","doi-asserted-by":"publisher","first-page":"e018023","DOI":"10.1161\/JAHA.120.018023","volume":"9","author":"CP Huded","year":"2020","unstructured":"Huded CP, Shah NP, Puri R, Nicholls SJ, Wolski K, Nissen SE, Cho L. Association of Serum Lipoprotein (a) Levels and Coronary Atheroma Volume by Intravascular Ultrasound. J Am Heart Assoc. 2020;9(23):e018023.","journal-title":"J Am Heart Assoc"},{"key":"6221_CR24","first-page":"101120","volume":"43","author":"A Kato","year":"2022","unstructured":"Kato A, Kinoshita D, Nagata T, Asakura K, Katamine M, Katsura A, Hashimoto T, Minami Y, Ako J. Lipoprotein (a) levels and vulnerable characteristics in nonculprit plaque in patients with acute coronary syndrome. Int J Cardiol Heart Vasc. 2022;43:101120.","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"4","key":"6221_CR25","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jacl.2018.03.090","volume":"12","author":"D Chieng","year":"2018","unstructured":"Chieng D, Pang J, Ellis KL, Hillis GS, Watts GF, Schultz CJ. Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease. J Clin Lipidol. 2018;12(4):1019\u201326.","journal-title":"J Clin Lipidol"},{"issue":"11","key":"6221_CR26","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/clc.23718","volume":"44","author":"X Shui","year":"2021","unstructured":"Shui X, Wen Z, Chen Z, Xie X, Wu Y, Zheng B, Wu Z, Chen L. Elevated serum lipoprotein(a) is significantly associated with angiographic progression of coronary artery disease. Clin Cardiol. 2021;44(11):1551\u20139.","journal-title":"Clin Cardiol"},{"issue":"16","key":"6221_CR27","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.jacc.2024.02.031","volume":"83","author":"ND Wong","year":"2024","unstructured":"Wong ND, Fan W, Hu X, Ballantyne C, Hoodgeveen RC, Tsai MY, Browne A, Budoff MJ. Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled Prospective Cohort. J Am Coll Cardiol. 2024;83(16):1511\u201325.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"6221_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/00019501-200603000-00010","volume":"17","author":"D Aras","year":"2006","unstructured":"Aras D, Geyik B, Topaloglu S, Ergun K, Ayaz S, Maden O, Yildiz A, Balci M, Ozeke O, Korkmaz S. Serum level of lipoprotein (a) is inversely associated with the development of coronary collateral circulation. Coron Artery Dis. 2006;17(2):159\u201363.","journal-title":"Coron Artery Dis"},{"issue":"8","key":"6221_CR29","doi-asserted-by":"publisher","first-page":"e5979","DOI":"10.1590\/1414-431x20175979","volume":"50","author":"Y Fan","year":"2017","unstructured":"Fan Y, Hu JS, Guo F, Lu ZB, Xia H. Lipoprotein(a) as a predictor of poor collateral circulation in patients with chronic stable coronary heart disease. Braz J Med Biol Res. 2017;50(8):e5979.","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"6221_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/joim.12981","volume":"287","author":"A Vuorio","year":"2020","unstructured":"Vuorio A, Watts GF, Schneider WJ, Tsimikas S, Kovanen PT. Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities. J Intern Med. 2020;287(1):2\u201318.","journal-title":"J Intern Med"},{"key":"6221_CR31","doi-asserted-by":"publisher","first-page":"1480501","DOI":"10.3389\/fcvm.2024.1480501","volume":"11","author":"S Zhang","year":"2024","unstructured":"Zhang S, Meng J, Zhou Y, Lv L, Zhang X. Prognostic value of the left ventricular ejection fraction reserve acquired by gated myocardial perfusion SPECT in patients with CAD and reduced stress LVEF. Front Cardiovasc Med. 2024;11:1480501.","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"6221_CR32","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1161\/CIRCRESAHA.119.316206","volume":"126","author":"JG Schnitzler","year":"2020","unstructured":"Schnitzler JG, Hoogeveen RM, Ali L, Prange KHM, Waissi F, van Weeghel M, Bachmann JC, Versloot M, Borrelli MJ, Yeang C, et al. Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation. Circ Res. 2020;126(10):1346\u201359.","journal-title":"Circ Res"},{"key":"6221_CR33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.phrs.2017.02.001","volume":"119","author":"M Pirro","year":"2017","unstructured":"Pirro M, Bianconi V, Paciullo F, Mannarino MR, Bagaglia F, Sahebkar A. Lipoprotein(a) and inflammation: A dangerous duet leading to endothelial loss of integrity. Pharmacol Res. 2017;119:178\u201387.","journal-title":"Pharmacol Res"},{"issue":"1","key":"6221_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40001-023-01029-2","volume":"28","author":"X Wang","year":"2023","unstructured":"Wang X, Hu Y, Luan H, Luo C, Kamila Kamili, Zheng T, Tian G. Predictive impact of fibrinogen-to-albumin ratio (FAR) for left ventricular dysfunction in acute coronary syndrome: a cross-sectional study. Eur J Med Res. 2023;28(1):68.","journal-title":"Eur J Med Res"},{"issue":"22","key":"6221_CR35","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1001\/jama.2009.801","volume":"301","author":"PR Kamstrup","year":"2009","unstructured":"Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA. 2009;301(22):2331\u20139.","journal-title":"JAMA"},{"issue":"1","key":"6221_CR36","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12944-023-01841-z","volume":"22","author":"J Zhang","year":"2023","unstructured":"Zhang J, Jia L, Yang Y, Xiao A, Lin X. Lipoprotein (a) and myocardial infarction: impact on long-term mortality. Lipids Health Dis. 2023;22(1):70.","journal-title":"Lipids Health Dis"},{"issue":"17","key":"6221_CR37","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.jacc.2008.01.028","volume":"51","author":"CW Yancy","year":"2008","unstructured":"Yancy CW, Abraham WT, Albert NM, Clare R, Stough WG, Gheorghiade M, Greenberg BH, O\u2019Connor CM, She L, Sun JL, et al. Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry. J Am Coll Cardiol. 2008;51(17):1675\u201384.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"6221_CR38","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.5114\/aoms.2016.59875","volume":"13","author":"Y Wang","year":"2017","unstructured":"Wang Y, Ma H, Yang J, Chen Q, Lu L, Zhang R. Lipoprotein(a) is associated with left ventricular systolic dysfunction in a Chinese population of patients with hypertension and without coronary artery disease. Arch Med Sci. 2017;13(5):1078\u201385.","journal-title":"Arch Med Sci"},{"issue":"1","key":"6221_CR39","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jchf.2015.08.006","volume":"4","author":"PR Kamstrup","year":"2016","unstructured":"Kamstrup PR, Nordestgaard BG. Elevated Lipoprotein(a) Levels, LPA Risk Genotypes, and Increased Risk of Heart Failure in the General Population. JACC Heart Fail. 2016;4(1):78\u201387.","journal-title":"JACC Heart Fail"},{"issue":"7","key":"6221_CR40","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/echo.15628","volume":"40","author":"L Askin","year":"2023","unstructured":"Askin L, Yuce E\u0130, Tanriverdi O. Myocardial performance index and cardiovascular diseases. Echocardiography. 2023;40(7):720\u20135.","journal-title":"Echocardiography"},{"issue":"8","key":"6221_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11886-017-0876-4","volume":"19","author":"AS Bhatt","year":"2017","unstructured":"Bhatt AS, Ambrosy AP, Velazquez EJ. Adverse Remodeling and Reverse Remodeling After Myocardial Infarction. Curr Cardiol Rep. 2017;19(8):71.","journal-title":"Curr Cardiol Rep"},{"issue":"17","key":"6221_CR42","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.jacc.2016.01.073","volume":"67","author":"PC Westman","year":"2016","unstructured":"Westman PC, Lipinski MJ, Luger D, Waksman R, Bonow RO, Wu E, Epstein SE. Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction. J Am Coll Cardiol. 2016;67(17):2050\u201360.","journal-title":"J Am Coll Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06221-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06221-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06221-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:41:43Z","timestamp":1790289703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06221-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6221"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06221-w","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was conducted according to the principles in the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"835"}}